• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    UCB’s Bimzelx outpacing AbbVie’s Rinvoq, Skyrizi on awareness

    FIERCE PHARMA

    AbbVie Commits $2.1B to Revolutionary Tumor-Fighting Tech

    PRESS RELEASE

    FDA approves AbbVie-Pfizer`s treatment for abdominal infections

    REUTERS

    Allergan, ASPS, Aesthetic Society Release Videos for Women Surgeons

    PR NEWSWIRE

    AbbVie projects over $31B in Skyrizi, Rinvoq sales by 2027

    FIERCE PHARMA

    AbbVie Revamps Emraclidine Expectations After Schizophrenia Failure

    BIOSPACE

    AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results

    PR NEWSWIRE

    NMC Probes Doctors Over AbbVie-Sponsored Foreign Trips

    ECONOMICTIMES

    Allergan`s AA Signature Program Unveiled At IMCAS 2025 Congress

    PR NEWSWIRE

    AbbVie crafts $1.6B deal with molecular glue biotech Neomorph

    PRESS RELEASE

    AbbVie Completes Acquisition of Nimble Therapeutics

    PR NEWSWIRE

    AbbVie pens $1B deal for Simcere’s phase 1 T-cell engager

    PRESS RELEASE

    AbCellera, AbbVie Partner to Develop Novel Oncology T-Cell Engagers

    BUSINESSWIRE

    Abbvie to record $3.5 bln charge related to schizophrenia drug

    REUTERS

    AbbVie to Present at Annual J.P. Morgan Healthcare Conference

    PR NEWSWIRE

    AbbVie first $40 M to advance Capsida-partnered CNS gene therapy

    FIERCE BIOTECH

    AbbVie cuts 2024 profit forecast on acquisition expenses

    REUTERS

    AbbVie to Host Full-Year and Q4 2024 Earnings Conference Call

    PR NEWSWIRE

    Pharma Dept Reprimands AbbVie for Unethical Marketing Practices

    BUSINESS STD

    AbbVie Healthcare under government lens for `violations`

    ECONOMICTIMES

    Novartis, AbbVie & PhRMA secure 340B court win in West Virginia

    ENDPTS

    AbbVie buys Roche spinout Nimble Therapeutics for $200M

    PRESS RELEASE

    AbbVie completes acquisition of Aliada Therapeutics

    INDPHARMAPOST

    New combination treatments promising for blood cancers

    REUTERS

    AbbVie Reports Emotional Impact Of CLL On Underrepresented Patients

    INDPHARMAPOST

    Roche`s subQ Lunsumio matches IV version in lymphoma

    FIERCE PHARMA

    AbbVie’s Parkinson’s drug succeeds in Phase 3 study

    PRESS RELEASE

    AbbVie Announces Positive Results for Tavapadon in Parkinson’s

    PR NEWSWIRE

    Epcoritamab Induces Durable Complete Responses in Two Analyses

    PR NEWSWIRE

    AbbVie CLL survey shows emotional impact on patients of color

    FIERCE PHARMA

    Epcoritamab Combo Shows High Response In Relapsed Follicular Lymphoma

    PR NEWSWIRE

    AbbVie’s Skyrizi retains DTC spending crown

    FIERCE PHARMA

    Alector’s AbbVie-Partnered Alzheimer’s Program Fails Ph 2

    BIOSPACE

    AbbVie to Present at Citi`s 2024 Global Healthcare Conference

    PR NEWSWIRE

    New IL-23 UC drugs `rapidly gained significant momentum`: report

    FIERCE PHARMA

    AbbVie makes `Rheum for Dialogue` with new patient resource

    FIERCE PHARMA

    AbbVie Receives EC Approval for ELAHERE® in Ovarian Cancer

    PR NEWSWIRE

    AbbVie names first Migraine Career Catalyst Award winners

    FIERCE PHARMA

    AbbVie Supports 20 Individuals with Migraine to Reach Career Goals

    PR NEWSWIRE

    AbbVie’s $9B bet collapses as schizophrenia drug fails studies

    BIOPHARMADIVE

    AbbVie & EvolveImmune Announce Cancer Biotherapeutics Collaboration

    GLOBENEWSWIRE

    AbbVie`s Skyrizi overtakes Humira as top sales driver

    FIERCE PHARMA

    AbbVie Reports Third-Quarter 2024 Financial Results

    PR NEWSWIRE

    SkinSpirit join Allergan Aesthetics in Empowering New Gen. of Women

    PRESS RELEASE

    SkinSpirit Joins Allergan In Supporting Girls Inc. STEM Initiative

    PR NEWSWIRE

    AbbVie to buy Alzheimer`s therapy developer Aliada for $1.4 bln

    REUTERS

    AbbVie makes Richter richer, paying $25M to form discovery pact

    FIERCE BIOTECH

    AbbVie & Gedeon Announce Collaboration For Neuropsychiatric Targets

    PR NEWSWIRE

    AbbVie`s Vyalev wins FDA nod in Parkinson`s after 2 rejections

    PRESS RELEASE

    Allergan Aesthetics Presents Data At ASDS 2024 Conference

    PR NEWSWIRE

    Lupin launches first generic of Pred Forte in the US

    EXPRESSPHARMA

    Dupixent takes pharma DTC top spot in September

    FIERCE PHARMA

    AbbVie’s Skyrizi passes Lilly’s Omvoh to take lead in colitis

    FIERCE PHARMA

    AbbVie cuts 2024 profit forecast citing R&D expenses

    REUTERS

    Enforcement Report - Week of October 2, 2024

    FDA

    EU withdraws marketing authorisation for Abbvie`s hepatitis C drug

    REUTERS

    AbbVie to Host Third-Quarter 2024 Earnings Conference Call

    PR NEWSWIRE

    AbbVie Submits BLA For Teliso-V In Non-Small Cell Lung Cancer

    PR NEWSWIRE

    AbbVie Announces Topline Results from Ph 3 Trial of Tavapadon

    PR NEWSWIRE

    AbbVie Announces Positive Tavapadon Phase 3 Results for PD

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.